PDGF R beta

PDGF R beta Overview

English NamePlatelet-derived growth factor receptor betaApproved Drugs11
Drugs in Clinical Trials24Target SynonymEC:2.7.10.1,PDGFRB,Platelet Derived Growth Factor Receptor Beta,Platelet-Derived Growth Factor Receptor, Beta Polypeptide,Beta-Type Platelet-Derived Growth Factor Receptor,PDGFR-Beta,PDGFR,Activated Tyrosine Kinase PDGFRB,CD140b Antigen,NDEL1-PDGFRB,EC 2.7.10.1,CD140B,JTK12,PENTT,IMF1,KOGS,IBGC4,Receptor, Platelet-Derived Growth Factor beta,Beta platelet-derived growth factor receptor,EC 2.7.10,CD140 antigen-like family member B,PDGFR-1,PDGF-R-beta,PDGFR1,Platelet-derived growth factor receptor 1,Platelet-derived growth factor receptor beta
Highest Development StageApproved
English NamePlatelet-derived growth factor receptor beta
Target SynonymEC:2.7.10.1,PDGFRB,Platelet Derived Growth Factor Receptor Beta,Platelet-Derived Growth Factor Receptor, Beta Polypeptide,Beta-Type Platelet-Derived Growth Factor Receptor,PDGFR-Beta,PDGFR,Activated Tyrosine Kinase PDGFRB,CD140b Antigen,NDEL1-PDGFRB,EC 2.7.10.1,CD140B,JTK12,PENTT,IMF1,KOGS,IBGC4,Receptor, Platelet-Derived Growth Factor beta,Beta platelet-derived growth factor receptor,EC 2.7.10,CD140 antigen-like family member B,PDGFR-1,PDGF-R-beta,PDGFR1,Platelet-derived growth factor receptor 1,Platelet-derived growth factor receptor beta
Approved Drugs11
Drugs in Clinical Trials24
Highest Development StageApproved

PDGF R beta Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    Fc Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
PDB-H5259
Human
HEK293
Human PDGF R beta / CD140b Protein, Fc Tag
Total: 1
  • 1

PDGF R beta Background

Human platelet-derived growth factor receptor, beta polypeptide (PDGFRB) is also called J03278, M21616, CD140B, JTK12, PDGF-R-beta and PDGFR, is receptor that binds specifically to PDGFB and has a tyrosine-protein kinase activity. Is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor (PDGF) family. The PDGFR/PDGF system includes two receptors (PDGFRA and PDGFRB) and four ligands (A, B, C and D). The receptors PDGFRA and PDGFRB are related in sequence and both are members of the class III subtype of receptor tyrosine kinases (RTKs). Other class III RTKs are CSF1R, KIT and FLT3. PDGF binding induces receptor homo- and heterodimerization and signal transduction. The expression of the α and β receptors is independently regulated in various cell types. Recombinant soluble PDGFRB binds PDGF with high affinity and is potent PDGF antagonist. The ligands form either homo- or heterodimers (PDGF-AA, -AB, -BB, -CC, -DD). The four PDGFs are inactive in their monomeric forms. The PDGFs bind to the protein tyrosine kinase receptors PDGF receptor-α and -β. These two receptor isoforms dimerize upon binding the PDGF dimer, leading to three possible receptor combinations, namely -αα, -ββ and -αβ. PDGF-CC specifically interacts with PDGFR-αα and -αβ, but not with –ββ, and thereby resembles PDGF-AB. PDGF-DD binds to PDGFR-ββ with high affinity, and to PDGFR-αβ to a much lower extent and is regarded as PDGFR-ββ specific. PDGF-AA binds only to PDGFR-αα, while PDGF-BB is the only PDGF that can bind all three receptor combinations with high affinity.

PDGF R beta Synonyms

PDGFRB,CD140B,JTK12,PDGF-R-beta,PDGFR-2,PDGFR-beta,PDGFR-β

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SeralutinibPK-10571; GB-002Phase 3 ClinicalGilead Sciences IncPulmonary Arterial Hypertension
Details
Crenolanib BesylateCP-868596-26; IND-112201; CP-868596; ARO-002; ARO-002-26; CP-868; 596-26; CP-868; 596Phase 3 ClinicalPfizer IncGastrointestinal Stromal Tumors; Glioma; Leukemia, Myeloid, Acute
Details
LucitanibS-80881; AL-3810; CO-3810; E-3810; S-80881-2Phase 2 ClinicalAdvenchen Laboratories Nanjing LtdBreast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Genital Neoplasms, Female; Lung Neoplasms; Metastatic breast cancer; Nasopharyngeal Carcinoma; Small Cell Lung Carcinoma; Solid tumours; Stomach Neoplasms; Thymus Neoplasms
Details
ZSP-1603ZSP-1603Phase 2 ClinicalGuangdong Zhongsheng Pharmaceutical Co Ltd, Wuxi Apptec Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Idiopathic Pulmonary Fibrosis; Liver Neoplasms; Ovarian Neoplasms; Solid tumours; Thyroid Neoplasms
Details
TelatinibEOC-315; BAY-57-9352Phase 2 ClinicalBayer AGSolid tumours; Stomach Neoplasms
Details
68Ga-BOT503568Ga-BOT5035Phase 2 ClinicalBiorion Technologies, Cortalix BVAtrial Fibrillation; Heart Failure
Details
Inhaled Nintedanib – dry powder (Avalyn Pharma)AP02; AP 02 DP; AP-02; AP02-DPPhase 2 ClinicalAvalyn Pharma IncIdiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis; Respiratory Tract Diseases
Details
Sorafenib Tosylate/ComekibartMG-D-1609Phase 2 ClinicalMetagone Biotech IncSolid tumours
Details
KDR2-2Phase 2 ClinicalGuangzhou Huiborui Biomedical Technology Co LtdCorneal Neovascularization; Glaucoma, Neovascular; Neovascularization, Pathologic
Details
KHK-4951Phase 2 ClinicalKyowa KirinDiabetic macular oedema; Macular Degeneration; Macular Edema; Wet Macular Degeneration
Details
Axitinib injectable suspension (Clearside Biomedical)CLS-1002; CLS-011-A; CLS011A; CLS-AXPhase 2 ClinicalClearside Biomedical IncMacular Degeneration
Details
Hydroxychloroquine/SorafenibPhase 2 ClinicalVg Life SciencesOvarian Neoplasms; Solid tumours
Details
18F-Dasatinib18F-SKI-249380; [18F]-Fluoro-BMS-354825; [18F]Dasatinib; [18F]SKI-249380; [18F]Fluoro-BMS-354825Phase 1 ClinicalMemorial Sloan Kettering Cancer CenterBone Marrow Neoplasms; Carcinoma; Diagnostic agents; Lymphoma; Melanoma; Neoplasms; Sarcoma
Details
nintedanib (Avalyn Pharma)Phase 1 ClinicalAvalyn Pharma IncIdiopathic Pulmonary Fibrosis; Pulmonary Fibrosis
Details
Tafetinib MalateSIM-0702; SIM-1005; SIM-010603Phase 1 ClinicalJiangsu Simcere Pharmaceutical Co Ltd, Jilin Boda Pharmaceutical Co Ltd, Nanjing Yoko Biomedical Co LtdNeoplasms
Details
MetarafenibPhase 1 ClinicalGuangzhou Nanxin Pharma Co LtdLiver Neoplasms; Solid tumours
Details
Nintedanib Esylate Inhalation Powder(Cspc)Phase 1 ClinicalCspc-Nbp Pharmaceutical Co LtdIdiopathic Pulmonary Fibrosis; Pulmonary Fibrosis
Details
DPH-001DPH-001; DPH001Phase 1 ClinicalDisruptive Pharma AB
Details
[68Ga]Ga-DOTA-Cys-ATH001[68Ga]Ga-DOTA-Cys-ATH001Phase 1 ClinicalAntaros Medical AbCholangitis, Sclerosing; Crohn Disease; Metabolic Dysfunction-Associated Steatotic Liver Disease
Details
MNKD-201MNKD-201; MKND-201Phase 1 ClinicalMannKind CorpIdiopathic Pulmonary Fibrosis
Details
ETN-101ETN101; ETN-101; MBP-11901Phase 1 ClinicalEtnova Therapeutics CorpCarcinoma, Hepatocellular; Liver Neoplasms
Details
T-1301T-1301; DBPR-216; BPR-1J481; BPR1J481Phase 1 ClinicalTaivex Therapeutics CorpLymphoma; Solid tumours
Details
ICP-033ICP-033Phase 1 ClinicalBeijing Innocare Pharma Tech Co LtdSolid tumours
Details
Sorafenib tosylate (Bio-Synectics)BS-104ClinicalBio-Synectics Inc
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Anlotinib DihydrochlorideAL-3818ApprovedAdvenchen Laboratories Llc, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd福可维Mainland ChinaCarcinoma, Non-Small-Cell LungJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd2018-05-08Bile Duct Diseases; Bone Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Colorectal Neoplasms; Craniopharyngioma; Endometrial Neoplasms; Esophageal Squamous Cell Carcinoma; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Gastroenteropancreatic neuroendocrine tumor; Gastroesophageal Junction Neoplasms; Gastrointestinal Stromal Tumors; Glioma; Head and Neck Neoplasms; Hepatic Insufficiency; Leiomyosarcoma; Liver Dysfunction; Lung Diseases, Interstitial; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Medullary thyroid cancer (MTC); Melanoma; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasms; Neuroendocrine Tumors; Osteoma; Ovarian Neoplasms; Peritoneal Neoplasms; Sarcoma; Sarcoma, Alveolar Soft Part; Sarcoma, Synovial; Small Cell Lung Carcinoma; Solid tumours; Stomach Neoplasms; Thoracic Neoplasms; Thyroid Neoplasms; Urologic Neoplasms; Uterine Cervical Neoplasms
Details
BecaplerminrhPDGF-BB (Janssen); RWJ-60235ApprovedJohnson & Johnson Innovative MedicineRegranexUnited StatesUlcer; Lower extremity diabetic neuropathic ulcersSmith & Nephew Healthcare Ltd1997-12-16Diabetic Foot; Diabetic Neuropathies; Foot Ulcer; Lower extremity diabetic neuropathic ulcers; Parkinson Disease; Skin Ulcer; Ulcer; Varicose Ulcer
Details
RegorafenibDAST; BAY-73-4506ApprovedBayer AGStivarga, ResihanceUnited StatesColorectal NeoplasmsBayer Healthcare Pharmaceuticals Inc2012-09-27Adenocarcinoma; Adenoma; Bile Duct Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Islet Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colonic Neoplasms; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Fallopian Tube Neoplasms; Gastrinoma; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Glucagonoma; Hemangiosarcoma; Insulinoma; Leukemia, Myeloid, Acute; Liver Neoplasms; Lung Neoplasms; Melanoma; Meningioma; Neoplasm Metastasis; Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Rectal Neoplasms; Sarcoma; Sarcoma, Ewing; Solid tumours; Somatostatinoma; Stomach Neoplasms; Thymoma; Thyroid Neoplasms
Details
Nintedanib EsylateBIBF-1120ApprovedC.H. Boehringer Sohn Ag & Co. KgOfev, VargatefUnited StatesIdiopathic Pulmonary FibrosisBoehringer Ingelheim International Gmbh2014-10-15Adenocarcinoma, Clear Cell; Appendiceal Neoplasms; Asbestosis; Astrocytoma; Breast Neoplasms; Carcinoid Tumor; Carcinoma, Endometrioid; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Endometrial Stromal Tumors; Esophageal Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Glioblastoma; Gliosarcoma; Hepatic Insufficiency; Idiopathic Pulmonary Fibrosis; Leukemia, Myeloid, Acute; Lung Diseases, Interstitial; Mesothelioma; Multiple Myeloma; Neoplasms; Oligodendroglioma; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Pulmonary Fibrosis; Radiation Pneumonitis; Rejection of lung transplantation; Sarcoma; Scleroderma, Systemic; Silicosis; Small Cell Lung Carcinoma; Solid tumours; systemic sclerosis-associated interstitial lung disease; Telangiectasia, Hereditary Hemorrhagic; Uterine Neoplasms
Details
RipretinibDCC-2618ApprovedDeciphera PharmaceuticalsQinlock, 擎乐United StatesGastrointestinal Stromal TumorsDeciphera Pharmaceuticals Llc2020-05-15Gastrointestinal Stromal Tumors; Mastocytosis, Systemic; Neoplasms
Details
Sunitinib MalatePNU-290940AD; PHA-290940AD; SCAI-003; SU-010398; SU-11248; GB-102; PHA-290940; PNU-290940; SU-011248-L-malate saltApprovedPfizer IncSutent, 索坦United StatesGastrointestinal Stromal Tumors; Carcinoma, Renal CellCppi Cv2006-01-26Abdominal Neoplasms; Adenocarcinoma; Adenocarcinoma, Follicular; Adenoma, Islet Cell; Adrenocortical Carcinoma; AIDS-Related Complex; Amyloidosis; Angioimmunoblastic T-cell Lymphoma; Astrocytoma; Barrett Esophagus; Brain metastases; Brain Neoplasms; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Carcinoma, Acinar Cell; Carcinoma, Adenoid Cystic; Carcinoma, Adenosquamous; Carcinoma, Embryonal; Carcinoma, Hepatocellular; Carcinoma, Islet Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Papillary; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Central Nervous System Neoplasms; Choriocarcinoma; Chronic eosinophilic leukemia (CEL); Cognition Disorders; Colorectal Neoplasms; Diabetic macular oedema; Endodermal Sinus Tumor; Endometrial Neoplasms; Ependymoma; Esophageal Neoplasms; Fallopian Tube Neoplasms; Fibromatosis, Aggressive; Fibrosarcoma; Gastrointestinal Stromal Tumors; Germinoma; Glioblastoma; Glioma; Gliosarcoma; Head and Neck Neoplasms; Hemangi
Details
Dasatinib HydrateNSC-732517; BMS-354825ApprovedBristol-Myers Squibb CompanySpraysel, 施达赛, Spricel, SprycelUnited StatesPrecursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, ChronicBristol-Myers Squibb Company2006-06-28Adenocarcinoma, Clear Cell; Angioimmunoblastic T-cell Lymphoma; Astrocytoma; Blast Crisis; Bone metastases; Brain Neoplasms; Breast Neoplasms; Burkitt Lymphoma; Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Cholangiocarcinoma; Chondrosarcoma; Chordoma; Colonic Neoplasms; Coronavirus Disease 2019 (COVID-19); Cystadenocarcinoma; Endometrial Neoplasms; Fallopian Tube Neoplasms; Gastrointestinal Stromal Tumors; Giant Cell Tumor of Bone; Glioblastoma; Glioma; Gliosarcoma; Heart Arrest; Hemangiopericytoma; Hematologic Neoplasms; HIV Infections; Hodgkin Disease; Hormone-Resistant Prostate Neoplasms; Hypereosinophilic Syndrome; Hypopharyngeal Neoplasms; Idiopathic Pulmonary Fibrosis; Immunoproliferative Small Intestinal Disease; Intraocular Lymphoma; Laryngeal Diseases; Laryngeal Neoplasms; Leukemia; Leukemia, Hairy Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myel
Details
Pazopanib HydrochlorideGSK-786034; GW-786034B; SB-786034; GW-786034ApprovedGlaxosmithkline Plc, Novartis Pharma Ag维全特, Armala, Votrient, PatormaUnited StatesCarcinoma, Renal Cell; SarcomaNovartis Pharma Ag2009-10-19Adenocarcinoma, Follicular; Brain Neoplasms; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Embryonal; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Central Nervous System Neoplasms; Chondrosarcoma; Chondrosarcoma, Extraskeletal Myxoid; Choriocarcinoma; Colorectal Neoplasms; Dermatofibrosarcoma; Endodermal Sinus Tumor; Epistaxis; Fallopian Tube Neoplasms; Fibromatosis, Aggressive; Gastrinoma; Gastroenteropancreatic neuroendocrine tumor; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Germinoma; Glioblastoma; Glioma; Gliosarcoma; Glucagonoma; Hemangiosarcoma; Herpes Genitalis; Herpes Simplex; HIV Infections; Hormone-Resistant Prostate Neoplasms; Insulinoma; Leiomyosarcoma; Leukemia, Myeloid, Acute; Liposarcoma; Lung Neoplasms; Lymphoma; Macular Degeneration; Medullary thyroid cancer (MTC); Melanoma; Mesothelioma; Multiple Endocrine Neoplasia T
Details
Becaplermin biosimilar (Virchow Group)ApprovedVirchow GroupHealace, Plermin gelDiabetic Foot
Details
Sorafenib TosylateNSC-724772; BAY-43-0006; BAY-43-9006; BAY-54-9085ApprovedOnyx Pharmaceuticals IncNexavar, 多吉美United StatesCarcinoma, Renal CellBayer Healthcare Pharmaceuticals Inc2005-12-01Abdominal Neoplasms; Adenocarcinoma; Angioimmunoblastic T-cell Lymphoma; Astrocytoma; Bile Duct Neoplasms; Brain Neoplasms; Breast Neoplasms; Breast Neoplasms, Male; Burkitt Lymphoma; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Islet Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Carcinoma, Verrucous; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Facial Neoplasms; Fallopian Tube Neoplasms; Fibromatosis, Aggressive; Gallbladder Neoplasms; Gastrinoma; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Glioblastoma; Gliosarcoma; Glucagonoma; Head and Neck Neoplasms; Heart Arrest; Hemangiosarcoma; Hepatopulmonary Syndrome; Histiocytoma, Malignant Fibrous; Hypertension, Portal; Hypopharyngeal Neoplasms; Insulinoma; Kidney Diseases; Kidney Neoplasms; Laryngeal Diseases; Laryngeal Neoplasms; Leiomyosarcoma; Leukemia, Basophilic, Acute; Leukemia, Eosin
Details
MidostaurinPKC-412; PKC-412A; CGP-41231; CGP-41251ApprovedNovartis Pharma AgRydaptUnited StatesHematologic Neoplasms; Leukemia, Myeloid, Acute; Mastocytosis, Systemic; Leukemia, Mast-CellNovartis Pharmaceuticals Corp2017-04-28Hematologic Neoplasms; Hepatic Insufficiency; Leukemia; Leukemia, Mast-Cell; Leukemia, Myeloid, Acute; Mastocytosis; Mastocytosis, Systemic; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
  • Overview
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland